ouabain has been researched along with flecainide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Fukami, M; Hashimoto, T; Itoh, Y; Koike, H; Kumakura, S; Miyake, S; Mizuno, H; Shiga, H; Shimoji, Y; Yorikane, R | 1 |
| Akiyama, K; Hashimoto, K | 1 |
| Banitt, EH; Newmark, RA; Schmid, JR | 1 |
| Haruno, A; Hashimoto, K | 1 |
| Matsumoto, S; Saiki, C; Takahashi, T; Takeda, M; Tanimoto, T | 1 |
| Bögeholz, N; Eckardt, L; Ellermann, C; Frommeyer, G; Lange, PS; Leitz, P; Puckhaber, D; Wolfes, J | 1 |
8 other study(ies) available for ouabain and flecainide
| Article | Year |
|---|---|
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Antiarrhythmic and cardiovascular profiles of the fused indole compound (3aR,12R,12aR,12bS)-12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydrox yisoquino [2,1,8-lma]carbazol-5(1H)-one hydrochloride 1.5 hydrate.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbazoles; Chloroform; Disopyramide; Dogs; Female; Flecainide; Heart; Heart Conduction System; Hemodynamics; Isoquinolines; Lidocaine; Male; Mexiletine; Mice; Mice, Inbred ICR; Myocardial Contraction; Ouabain | 1991 |
Antiarrhythmic effects of the class 1c antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models.
Topics: Animals; Arrhythmias, Cardiac; Coronary Vessels; Disease Models, Animal; Dogs; Epinephrine; Flecainide; Ligation; Ouabain | 1989 |
Resolution of flecainide acetate, N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzam ide acetate, and antiarrhythmic properties of the enantiomers.
Topics: Animals; Anti-Arrhythmia Agents; Chloroform; Dogs; Female; Flecainide; Magnetic Resonance Spectroscopy; Mice; Ouabain; Piperidines; Stereoisomerism; Tachycardia; Ventricular Fibrillation | 1986 |
Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Chlorobenzenes; Digitalis Glycosides; Disease Models, Animal; Disopyramide; Dogs; Epinephrine; Female; Flecainide; Injections, Intra-Arterial; Lidocaine; Male; Ouabain; Verapamil | 1995 |
Effects of ouabain and flecainide on CO(2)-induced slowly adapting pulmonary stretch receptor inhibition in the rabbit.
Topics: Adaptation, Physiological; Animals; Blood Pressure; Carbon Dioxide; Female; Flecainide; Male; Ouabain; Pulmonary Stretch Receptors; Pulmonary Ventilation; Rabbits; Respiration, Artificial; Sodium Channel Blockers; Sodium Channels; Sodium-Potassium-Exchanging ATPase; Time Factors; Trachea; Vagus Nerve; Veratridine | 2000 |
Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated Hearts.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotoxicity; Digitalis Glycosides; Drug Interactions; Flecainide; Heart Rate; Isolated Heart Preparation; Ouabain; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Risk Assessment; Time Factors; Voltage-Gated Sodium Channel Blockers | 2019 |